MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-24-0018513
Brooks Steriscience Limited - pharma in Karjan, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹16.45 Cr
▼ 20% YoY
Net loss · FY 2023
₹26.79 Cr
Net margin -162.9%
EBITDA · FY 2023
-₹26.68 Cr
EBITDA margin -162.2%
Authorised capital
₹98.42 Cr
Registered with MCA
Paid-up capital
₹31.36 Lakh
Issued & subscribed
Open charges
₹68.62 Cr
Satisfied ₹23.39 Cr
Company age
6 yrs
Est. 2020
Employees · EPFO
174
Provident fund records
About Brooks Steriscience Limited
Data last updated:
Brooks Steriscience Limited is a public limited company based in Karjan, Gujarat, India, a subsidiary of Steriscience Specialties Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24297MH2020PLC465110. Its GSTIN is 27AAJCB2427Q1Z8 (Maharashtra). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹98.42 Cr and a paid-up capital of ₹31.36 Lakh. It is led by directors including Santosh Kumar Khare (Whole-Time Director) and Chamarahalli Sundhar Krishna Iyer.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block No. Survey No. 61/62 Manglej Village, Nareshwar Road Karjan Taluka Vadodara Gujarat, Gujarat, India – 391243.
As per the financials filed for FY 2023, the company reported a revenue of ₹16.45 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net loss of ₹26.79 Cr (net margin -162.9%) and EBITDA of -₹26.68 Cr (EBITDA margin -162.2%).
The company has about 174 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹68.62 Cr and satisfied charges of ₹23.39 Cr on record. Court records list 1 case involving the company, including 1 filed against it. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹161.06 Cr; the latest was in August 2021. Its 10 peer companies in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Solana Life Sciences Private Limited with revenue of ₹16.49 Cr. The company has 8 MSME Form 1 returns on record between 2021 and 2024, listing 346 overdue payments to 146 micro and small suppliers.
Brooks Steriscience Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0018513). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brookslabs.net.
Company details
CIN U24297MH2020PLC465110
Registration Number 116152
Incorporation Date 04 September 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Steriscience Specialties Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-24-0018513
CIN history
Brooks Steriscience has one previous CIN (Corporate Identification Number): U24297GJ2020PLC116152. The current CIN is U24297MH2020PLC465110, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24297MH2020PLC465110 | Current |
| U24297GJ2020PLC116152 | Previous |
Key People
Santosh Kumar Khare Whole-Time Director Chamarahalli Sundhar Krishna Iyer Director Chhitiz Saraogi Additional Director Recognitions & Rankings of Brooks Steriscience
Contact details
Brooks Steriscience Limited's registered office is in Karjan, Gujarat.
- Registered AddressBlock No. Survey No. 61/62 Manglej Village, Nareshwar Road Karjan Taluka Vadodara Gujarat, Gujarat, India – 391243
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Brooks Steriscience Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Brooks Steriscience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Brooks Steriscience Limited, buy the company report.
Financials of Brooks Steriscience Limited
FY 2025 filings availableBrooks Steriscience Limited reported revenue of ₹16.45 Cr (down 20% YoY) for FY 2023.
Revenue · FY 2023
₹16.45 Cr ▼ 20%
Net loss · FY 2023
₹26.79 Cr margin -162.9%
EBITDA · FY 2023
-₹26.68 Cr margin -162.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 20%
EBITDA CAGR growth
1 year
▼ 65%
Revenue fell 20% in the latest year. EBITDA fell 65% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹16.45 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹26.68 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹26.79 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -162.2% | ||
| Net Profit Margin | -162.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Brooks Steriscience Limited, buy the company report.
Board of directors of Brooks Steriscience Limited
Brooks Steriscience has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chamarahalli Sundhar Krishna Iyer | Director | 29 May 2023 | 3 Years 5 Months | Current |
| Santosh Kumar Khare | Whole-Time Director | 21 Oct 2021 | 5 Years 0 Months | Current |
| Chhitiz Saraogi Also directs: Steriscience Specialties Private Limited | Additional Director | 01 Jan 2025 | 1 Years 9 Months | Current |
| Pudhucode Radhakrishnan Kannan Also directs: Dvise Medtech Private Limited, Serovia Pharma Private Limited, Dvise Pharma Tech Private Limited and 4 more | Additional Director | 01 Jan 2025 | 1 Years 9 Months | Current |
| Atul Ranchal Also directs: Abridge Speciality Limited | Director | 22 Sep 2023 | 3 Years 1 Months | Current |
Peer comparison
Brooks Steriscience Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Solana Life Sciences Private Limited | ₹16.49 Cr (FY 2024) | 18.0% | Dhar, Madhya Pradesh, India | |||
| Crysta Crop Science Private Limited | ₹16.48 Cr (FY 2025) | 32.0% | Bhavnagar, Gujarat, India | |||
| Grace Organics Private Limited | ₹16.47 Cr (FY 2024) | 1.0% | Mumbai, Maharashtra, India | |||
| Advatech Life Science Private Limited | ₹16.46 Cr (FY 2025) | 373.0% | Jhagadia, Gujarat, India | |||
| Azkka Pharmaceuticals Private Limited | ₹16.46 Cr (FY 2025) | 16.0% | Ahmedabad, Gujarat, India | |||
| Brooks Steriscience Limitedthis company | ₹16.45 Cr (FY 2023) | -₹26.79 Cr | -162.9% | -20.0% | Karjan, Gujarat, India | |
| Newchem Sunraysia Private Limited | ₹16.44 Cr (FY 2025) | 11.0% | Nashik, Maharashtra, India | |||
| East Drug Marchants Private Limited | ₹16.43 Cr (FY 2024) | 137.0% | Kolkata, West Bengal, India | |||
| Bioiv Labs Private Limited | ₹16.43 Cr (FY 2024) | 509.0% | Nalagarh, Himachal Pradesh, India | |||
| Anshu Chemicals Private Limited | ₹16.41 Cr (FY 2024) | -18.0% | Delhi, India | |||
| Pharmachemie Engineering and Consultants Private Limited | ₹16.38 Cr (FY 2024) | 707.0% | Thane, Maharashtra, India |
To see the full peer comparison of Brooks Steriscience Limited, buy the company report.
Charges & borrowings
Open charges
₹68.62 Cr
Satisfied charges
₹23.39 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Aug 2023 | 100774755 | Others | ₹68.62 Cr | Open | |
| 25 Mar 2021 | 100444113 | Indian Bank | ₹4 Cr | Satisfied | |
| 25 Mar 2021 | 100444134 | Indian Bank | ₹8.53 Cr | Satisfied | |
| 25 Mar 2021 | 100444145 | Indian Bank | ₹7 Cr | Satisfied | |
| 25 Mar 2021 | 100444146 | Indian Bank | ₹3.23 Cr | Satisfied |
To see the full charge records of Brooks Steriscience Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Brooks Steriscience Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹161.06 Cr; the latest was in August 2021.
Total deals
2
Funding rounds
2
Disclosed funding
₹161.06 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2021 | Funding round | ₹141.06 Cr | Investors: Steriscience Specialties Private Limited , Brooks Laboratories Limited |
| Dec 2020 | Funding round | ₹20 Cr | Investors: Steriscience Specialties Private Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Brooks Steriscience Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Civil suit | Filed against the company by SGD Pharma India Private Limited | Disposed |
To see the full case history of Brooks Steriscience Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Brooks Steriscience Limited was last rated by Care on 05 Nov 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 05 Nov 2021 |
To see the full credit ratings and regulatory alerts of Brooks Steriscience Limited, buy the company report.
MSME payment delays
Brooks Steriscience Limited has 8 MSME Form 1 returns on record between 2021 and 2024, listing 346 overdue payments to 146 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 146)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Spectrum Pharmatech Consultants Private Limited | |||
| an individual supplier | |||
| Qualikems Lifesciences Private Limited | |||
| an individual supplier | |||
| Gatulal V Patel |
To see the full MSME payment records of Brooks Steriscience Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Brooks Steriscience has 5 GST registrations: 4 active and 1 cancelled or inactive.
Total GSTINs
5
Active
4
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCB2427Q1Z8 | Maharashtra | Active | 09 Apr 2021 |
| 24AAJCB2427Q1ZE | Gujarat | Active | 17 Nov 2020 |
| 02AAJCB2427Q1ZK | Himachal Pradesh | Active | 01 Feb 2023 |
| 19AAJCB2427Q1Z5 | West Bengal | Active | 13 Mar 2023 |
To see the full GST registrations and return filing status of Brooks Steriscience Limited, buy the company report.
Recent activity
Brooks Steriscience Limited has 12 board changes on record since 2021: 5 appointments and 7 cessations. The latest: Chhitiz Saraogi was appointed as Additional Director on 01 Jan 2025.
AGM
Brooks Steriscience Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records.
Filing
Brooks Steriscience Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Chhitiz Saraogi was appointed as Additional Director.
Appointed
Pudhucode Radhakrishnan Kannan was appointed as Additional Director.
Charges
A charge registered on 25 Mar 2021 via Charge ID 100444113 with Indian Bank was fully satisfied on 31 Dec 2024.
Charges
A charge registered on 25 Mar 2021 via Charge ID 100444134 with Indian Bank was fully satisfied on 31 Dec 2024.
Charges
A charge registered on 25 Mar 2021 via Charge ID 100444145 with Indian Bank was fully satisfied on 31 Dec 2024.
Charges
A charge registered on 25 Mar 2021 via Charge ID 100444146 with Indian Bank was fully satisfied on 31 Dec 2024.
Charges
A charge registered on 25 Mar 2021 via Charge ID 100444166 with Indian Bank was fully satisfied on 31 Dec 2024.
Charges
A charge with Others of Rs. 68.62 Cr registered on 13 Aug 2023 with Charge ID 100774755 was modified on 19 Dec 2024.
Appointed
Atul Ranchal was appointed as Director.
Ceased
Chamarahalli Sundhar Krishna Iyer ceased to be Additional Director.
20 earlier events are in the company report.
News
Frequently asked questions
Brooks Steriscience is an active public limited company based in Karjan, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 September 2020 (6+ years old) and is registered under CIN U24297MH2020PLC465110.
Brooks Steriscience has 5 current directors:
- Santosh Kumar Khare - Whole-Time Director
- Chamarahalli Sundhar Krishna Iyer - Director
- Chhitiz Saraogi - Additional Director
- Pudhucode Radhakrishnan Kannan - Additional Director
- Atul Ranchal - Director
The latest financial statements of Brooks Steriscience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Brooks Steriscience is 27AAJCB2427Q1Z8, registered in Maharashtra. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAJCB2427Q1ZE (Gujarat), 02AAJCB2427Q1ZK (Himachal Pradesh), 19AAJCB2427Q1Z5 (West Bengal).
The CIN (Corporate Identification Number) of Brooks Steriscience is U24297MH2020PLC465110. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brooks Steriscience has 1 court case on record: 1 filed against it.
Brooks Steriscience was incorporated on 04 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Brooks Steriscience has 2 deals on record (2 funding rounds), with disclosed funding of ₹161.06 Cr; the latest was in August 2021.
The peers of Brooks Steriscience by revenue are Solana Life Sciences Private Limited, Crysta Crop Science Private Limited, Grace Organics Private Limited, Advatech Life Science Private Limited, Azkka Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chhitiz Saraogi was appointed as Additional Director on 01 Jan 2025. Pudhucode Radhakrishnan Kannan was appointed as Additional Director on 01 Jan 2025. Atul Ranchal was appointed as Director on 22 Sep 2023. Brooks Steriscience has 12 board changes on record in total.
Yes, Brooks Steriscience is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-24-0018513).
Brooks Steriscience has 8 MSME Form 1 returns on record between 2021 and 2024, listing 346 overdue payments to 146 micro and small suppliers. The latest return was filed on 30 Apr 2024.